The most cited paper to ever be retracted: a stem cell fraud?
Corenna Twiss reports on the recent retraction of a seminal stem cell paper with over 4,500 citations due to evidence of data falsification.
BioArt: Producing art through biochemistry
Edie Allden explores the artistic side of biochemistry and how ethics and access challenge the universality of BioArt.
Viral Whodunit: Investigating the origins of SARS-CoV-2
Eloise Elkington explores the largely disputed origins of COVID-19 and how evidence suggests but not proves a wet market origin.
The power of the Immune Clock—how the circadian rhythm affects our immune system
Waywen Loh discusses the daily cycle of our immune system and how this can be exploited during vaccination.
Blue energy—harnessing the power of tropical waters for a greener future
Matthew Rogers explores the green technology ocean thermal energy conversion, which could be better than conventional renewable energy.
The Oxford Scientist Michaelmas reading and watchlist
Culture editors Catherine Wang and Erin Adlard give recommendations for this term’s must-watch and must-reads for those who love science.
IP landmark cases: G01/07 (treatment by surgery)
In the fourth instalment of the IP landmark case series, Emanuel Bor reflects on the case that determined the patentability of surgery.
The most cited paper to ever be retracted: a stem cell fraud?
Corenna Twiss reports on the recent retraction of a seminal stem cell paper with over 4,500 citations due to evidence of data falsification.
Pioneers of machine learning awarded the 2024 Nobel Prize in Physics
Andrea La Fleur reports on how John Hopfield and Geoffrey Hinton won the Nobel Prize in physics for their work on machine learning.
What is happening with the Marburg virus?
Angelina Shcherbakova reports on the recent outbreak of the Marburg virus and how Rwanda are dealing with this public health concern.
IP landmark cases: Association of Molecular Pathology v. Myriad Genetics, Inc.
Emanuel Bor releases the third article in his IP landmark cases series where he reveals whether DNA can be patented.
From lab to plate—the future of meat alternatives
Mia Clark-Webb reflects on the future of meat alternatives and how lab grown cultured meat is taking science by storm.
IP landmark cases: Diamond v. Chakrabarty
Emanuel Bor summarises a key IP landmark case where it was decided whether a living organism can be patented.
Evolutionary mismatch and the metabolic trident
Malintha Hewa Batage reflects on evolutionary mismatch and how our metabolic genes are not well-matched with a modern, sedentary lifestyle.
IP landmark cases: the basics
Emanuel Bor kicks off the new IP landmark cases series by explaining what a patent is and the process needed to obtain one.
